Xueping Yu

2.7k total citations
77 papers, 1.9k citations indexed

About

Xueping Yu is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Xueping Yu has authored 77 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 22 papers in Molecular Biology and 22 papers in Hepatology. Recurrent topics in Xueping Yu's work include Hepatitis B Virus Studies (25 papers), Liver Disease Diagnosis and Treatment (21 papers) and Hepatitis C virus research (17 papers). Xueping Yu is often cited by papers focused on Hepatitis B Virus Studies (25 papers), Liver Disease Diagnosis and Treatment (21 papers) and Hepatitis C virus research (17 papers). Xueping Yu collaborates with scholars based in China, United States and Germany. Xueping Yu's co-authors include Jiang Qian, Donald J. Zack, Heng Zhu, Anders Wallqvist, Jimmy Lin, Xiong Liu, Jaques Reifman, Zhijun Su, Ruifeng Liu and Jiming Zhang and has published in prestigious journals such as Cell, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Xueping Yu

71 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueping Yu China 25 1.0k 433 256 241 190 77 1.9k
Jun Hayashi Japan 26 622 0.6× 396 0.9× 228 0.9× 406 1.7× 99 0.5× 149 2.3k
Hongsong Chen China 23 767 0.7× 490 1.1× 436 1.7× 544 2.3× 268 1.4× 111 1.9k
Yu‐Chao Wang Taiwan 24 731 0.7× 166 0.4× 138 0.5× 166 0.7× 156 0.8× 120 1.8k
Tao-Hsin Chang Taiwan 14 835 0.8× 349 0.8× 265 1.0× 129 0.5× 54 0.3× 29 1.5k
Xudong Wu China 25 971 0.9× 502 1.2× 112 0.4× 427 1.8× 168 0.9× 64 2.1k
Franco Turrini Italy 27 883 0.8× 300 0.7× 272 1.1× 323 1.3× 74 0.4× 50 2.6k
Sascha Bulik Germany 18 1.1k 1.1× 232 0.5× 58 0.2× 352 1.5× 109 0.6× 27 1.5k
David W. A. Beno United States 21 491 0.5× 294 0.7× 250 1.0× 186 0.8× 87 0.5× 54 1.4k
Hua-Chien Chen Taiwan 14 1.1k 1.0× 325 0.8× 114 0.4× 108 0.4× 839 4.4× 14 1.8k

Countries citing papers authored by Xueping Yu

Since Specialization
Citations

This map shows the geographic impact of Xueping Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueping Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueping Yu more than expected).

Fields of papers citing papers by Xueping Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueping Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueping Yu. The network helps show where Xueping Yu may publish in the future.

Co-authorship network of co-authors of Xueping Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xueping Yu. A scholar is included among the top collaborators of Xueping Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueping Yu. Xueping Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Zhixiang, et al.. (2025). Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α. Therapeutic Advances in Gastroenterology. 18. 1128501013–1128501013. 1 indexed citations
2.
Zhang, Hongyan, et al.. (2024). Akkermansia muciniphila ONE effectively ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis in mice. npj Science of Food. 8(1). 97–97. 11 indexed citations
3.
Zhu, Na, et al.. (2024). Research on preventive effect of Akkermansia muciniphilaAKK PROBIO on acute gouty arthritis in mice. Food Science & Nutrition. 12(10). 7644–7656. 5 indexed citations
4.
Zheng, Qi, Xueping Yu, Airong Hu, et al.. (2024). Determining optimal ALT cut‐off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary Pharmacology & Therapeutics. 59(5). 692–704. 1 indexed citations
5.
Zhang, Shenyan, Xueping Yu, Jinyu Wang, et al.. (2024). Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus. Journal of Virology. 98(2). e0134523–e0134523. 4 indexed citations
6.
Yu, Xueping, et al.. (2024). Genome- and Toxicology-Based Safety Assessment of Probiotic Akkermansia muciniphila ONE Isolated from Humans. Foods. 13(13). 1979–1979. 7 indexed citations
7.
Tian, Meng, Xueping Yu, Ming Liu, et al.. (2024). Characterization and Preliminary Safety Evaluation of Akkermansia muciniphila PROBIO. Foods. 13(3). 442–442. 12 indexed citations
8.
Zheng, Jia, Wei Zou, & Xueping Yu. (2023). Autophagy in Intracerebral Hemorrhage: From Mechanism to Regulation. Journal of Integrative Neuroscience. 22(5). 134–134. 6 indexed citations
9.
Zhou, Xu, Ya‐Fang Chen, Xin Ma, et al.. (2022). Efficacy of Bacillus coagulans BC01 on loperamide hydrochloride-induced constipation model in Kunming mice. Frontiers in Nutrition. 9. 964257–964257. 20 indexed citations
10.
Sun, Jian, Hongying Guo, Xueping Yu, et al.. (2021). A neutrophil-to-lymphocyte ratio-based prognostic model to predict mortality in patients with HBV-related acute-on-chronic liver failure. BMC Gastroenterology. 21(1). 422–422. 16 indexed citations
11.
Guo, Hongying, Shu Li, Jing Li, et al.. (2019). Development and Validation of a Novel Model to Predict Liver Histopathology in Patients with Chronic Hepatitis B. BioMed Research International. 2019. 1–8. 3 indexed citations
12.
Yang, Feifei, Xueping Yu, Chenliang Zhou, et al.. (2019). Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection. PLoS Pathogens. 15(4). e1007690–e1007690. 59 indexed citations
13.
Dong, Minhui, Jingwen Wu, Xueping Yu, et al.. (2018). Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients. Liver International. 38(9). 1562–1570. 35 indexed citations
14.
Shen, Zhiqing, Xueping Yu, Huatang Zhang, et al.. (2018). CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker. OncoTargets and Therapy. Volume 11. 891–901. 39 indexed citations
15.
Liu, Ruifeng, Mohamed Diwan M. AbdulHameed, Kamal Kumar, et al.. (2017). Data-driven prediction of adverse drug reactions induced by drug-drug interactions. BMC Pharmacology and Toxicology. 18(1). 44–44. 37 indexed citations
16.
Ming, Desong, et al.. (2015). Elevated TGF-β1/IL-31 Pathway Is Associated with the Disease Severity of Hepatitis B Virus–Related Liver Cirrhosis. Viral Immunology. 28(4). 209–216. 30 indexed citations
17.
Feala, Jacob, Mohamed Diwan M. AbdulHameed, Chenggang Yu, et al.. (2013). Systems Biology Approaches for Discovering Biomarkers for Traumatic Brain Injury. Journal of Neurotrauma. 30(13). 1101–1116. 40 indexed citations
18.
Memišević, Vesna, Nela Zavaljevski, Rembert Pieper, et al.. (2013). Novel Burkholderia mallei Virulence Factors Linked to Specific Host-Pathogen Protein Interactions. Molecular & Cellular Proteomics. 12(11). 3036–3051. 32 indexed citations
20.
Liu, Xiong, Xueping Yu, Donald J. Zack, Heng Zhu, & Jiang Qian. (2008). TiGER: A database for tissue-specific gene expression and regulation. BMC Bioinformatics. 9(1). 271–271. 296 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026